The latest version of Instron’s Autoinjector Testing System was developed in close collaboration with CDMOs and pharmaceutical device manufacturers. It can perform thorough functioning testing on ...
The global auto-injectors market is on a significant growth trajectory, with market share expected to reach a robust valuation of USD 30,578.2 million in 2023. This figure represents a strong presence ...
The research serves as a manual and road map for doing an exhaustive investigation of the worldwide industry, target market, rivalry, and other factors. The “Vietnam Epinephrine Autoinjector Market ” ...
poses a challenge. Key market players include AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd ...
NEW YORK, Sept. 9, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global autoinjectors market size is estimated to grow by USD 303.65 billion from 2024-2028, according to ...
New Yorkers will soon be able to more easily afford essential, life-saving epinephrine auto-injector, or EpiPen, devices. Health insurers in individual and group markets — including non-profit ...
Rx Bandz is a multi-asset biotech developing a platform of patient-centric auto-injectors and life-saving drug formulations Under the Zeyco Group umbrella, Laboratorios Zeyco is a pharmaceutical ...
ALBANY, N.Y. — Governor Kathy Hochul on Thursday signed legislation that will reduce the sky-high costs of epinephrine auto-injector ("EpiPen") devices for consumers with commercial health insurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results